Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Implantable Neurostimulation Devices Market Expected to Grow Between 2025 And 2029?

The market for implantable neurostimulation devices has seen swift expansion in recent years. It is projected to rise from a value of $5.02 billion in 2024 to $5.62 billion in 2025, experiencing a compound annual growth rate (CAGR) of 11.8%. The upsurge in growth during the historic period can be linked to a growing preference for non-pharmacological treatments, increased interest in minimally invasive procedures, a rising geriatric demographic, an expanding array of psychiatric disorders, and a growing incidence of chronic diseases.

Anticipated to witness swift expansion in the upcoming years, the market size of implantable neurostimulation devices is predicted to reach $8.86 billion in 2029, growing at a compound annual growth rate (CAGR) of 12.1%. The ascension during the forecast period can be credited to the escalating prevalence of neurological maladies, increase in lifestyle disorders, heightened consciousness, raising incidence of spinal cord injuries, and boost in healthcare expenses. The prediction period is marked with key trends such as sensor technology, progressive improvements in neurostimulation technologies, state-of-the-art products, the inclusion of closed-loop systems, and the application of wireless technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp

Which Primay Drivers Are Accelerating Growth in the Implantable Neurostimulation Devices Market?

The anticipated surge in neurological disorders is predicted to accelerate the growth of the implantable neurostimulation device market. Neurological disorders, encompassing any ailment that compromises the structure or functionality of the nervous system, cause various symptoms – from paralysis and seizures to cognitive difficulties. The heightened exposure to risk factors like high blood pressure, developmental irregularities, and trauma could potentially increase the detection of such disorders. Implantable neurostimulation devices, aiding in nerve activity modulation and symptom alleviation, are thus utilized when other treatments yield little to no effectiveness. For example, by 2024, the Alzheimer’s Association, an American non-profit healthcare organization, estimates that 6.9 million Americans older than 65 will live with Alzheimer’s disease, with 73% of them being 75 or older. The figure is expected to escalate to 12.7 million by 2050. Hence, the surging cases of neurological disorders would contribute to the growth of the implantable neurostimulation device market.

Which Primary Segments of the Implantable Neurostimulation Devices Market Are Driving Growth and Industry Transformations?

The implantable neurostimulation devicesmarket covered in this report is segmented –

1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types

2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices

2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators

3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders

4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence

5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression

6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19520&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Implantable Neurostimulation Devices Market?# Market?

North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Implantable Neurostimulation Devices Industry Dynamics?

Leading players in the market of implantable neurostimulation devices are concentrating their efforts on creating cutting-edge products, like spinal cord stimulation (SCS) systems, to mitigate persistent pain conditions. The SCS system is a medical instrument that employs electrical signals to control nerve activity in the spinal cord, providing chronic pain relief and enhancing patients’ quality of life when other methods fail. For example, in December 2022, Abbott, an American medical device firm, disclosed the approval of the Eterna spinal cord stimulation (SCS) system by the U.S. Food and Drug Administration (FDA). The Eterna SCS, as the smallest implantable, rechargeable spinal cord stimulator in the market, is designed for optimum daily comfort. It relies on Abbott’s proprietary BurstDR stimulation technology, which simulates the brain’s natural firing patterns for superior pain relief, chosen by 87% of patients over traditional tingling stimulation. Featuring minimal recharging needs, with the Xtend energy technology that only requires as few as five recharges yearly, Eterna ensures user convenience. It is compatible with full-body MRI scans due to its TotalScan technology, and it can adapt to future technological improvements without needing replacement. Additionally, Abbott’s mobile app integration allows for the real-time monitoring of battery life and charging status on iPhone devices.

View the full report here:

https://www.thebusinessresearchcompany.com/report/implantable-neurostimulation-devices-global-market-report

What Parameters Are Used to Define the Implantable Neurostimulation Devices Market?

Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body and are used to modulate nerve activity. The devices represent a sophisticated approach to managing conditions that may not respond well to medication alone, offering patients a chance to improve their quality of life.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19520

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model